甲基苯丙胺抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 甲基苯丙胺抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected 甲基苯丙胺抗体to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH甲基苯丙胺抗体 induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.

Also known as:

甲基苯丙胺抗体d-Desoxyephedrine hydrochloride; d-N; α-Dimethylphenethylamine hydrochloride; Methylamphetamine hydrochloride.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Methamphetamine.

●

Immunogen: KLH conjugated to Methamphetamine.

●

Predicted Molecular Weight: 0.18569kDa.

甲基苯丙胺抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl130Ra01组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl130Rb51组织金属蛋白酶抑制因子4(TIMP4)多克隆抗体Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)

kl131Bo01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Fi01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Hu01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Mu01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Po01转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl131Rb51转化生长因子β诱导蛋白(TGFβI)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)

kl132Hu01脂联素受体2(ADIPOR2)多克隆抗体Polyclonal Antibody to Adiponectin Receptor 2 (ADIPOR2)

kl132Ra01脂联素受体2(ADIPOR2)多克隆抗体Polyclonal Antibody to Adiponectin Receptor 2 (ADIPOR2)

kl134Bo01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Ca01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Hu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Mu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Po01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Ra01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Rb51肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Si01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl135Bo01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ca01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ga01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Hu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Mu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)